Answers are grounded in this paper and cite their sources.
Background Despite progress in reducing the time from HIV diagnosis to treatment initiation, achieving sustained viral suppression remains a major public health challenge among people living with HIV in Ethiopia. However, evidence on viral suppression and its predictors during the test-and-treat era remains limited. Objective This study aimed to assess the rate and predictors of viral suppression among adolescents and adults living with HIV during the test-and-treat era, January 2018 to December 2022, Shashemene City, Ethiopia. Methods A retrospective cohort study was conducted among 414 patients aged 15 years and older who initiated ART between January 2018 and December 2021. Patients were selected using a proportional stratified random sampling technique and followed for a maximum of two years in public health facilities in Shashemene City. Kaplan-Meier was used to estimate the median time to viral suppression, and Cox proportional hazards regression identified predictors of suppression. Results Of the 414 patients, 290 (70.05%; 95% CI: 65.64–74.46) achieved viral suppression by the end of the follow-up period (December 2022). The rate of viral suppression was 6.68 per 100 person-months (95%CI: 5.95–7.49), and the median time to suppression was 9.33 months (95%CI: 8.55–10.11). Rapid ART initiation was associated with twofold higher likelihood of early suppression (aHR = 2.05, 95%CI: 1.58–2.67) compared to delayed initiation. Undernourished patients had 46% lower chance of early suppression (aHR = 0.54, 95%CI: 0.36–0.81), and those who were ambulatory/bedridden at baseline had an 87% lower chance (aHR = 0.13; 95%CI: 0.07–0.27) than working patients. Not good adherence lowered suppression by 36% (aHR = 0.64; 95%CI: 0.41–0.99). Conclusion and recommendation The viral suppression rate was well below the UNAIDS target of 95%. Strengthening rapid ART initiation, adherence and providing nutritional support are essential to improve outcomes. Lower suppression rates among ambulatory/bedridden patients could partly reflect additional health challenges influencing treatment response.
No takes yet. Share an insight, caveat, or question.
Jarso et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: